Home

J KENNETH GLASS

CIK 1224966 · last filed 2018-05-11

J KENNETH GLASS is a corporate insider who has filed 35 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for GTXI, was dated May 11, 2018. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.75M

Companies

2

Total Filings

35

Lifetime Open-Market Net

-$1.73M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oncternal Therapeutics, Inc. (GTXI) Delisted Director 32,046 — — $439.0K 33 2018-05-11
FHN Director 499,578 $25.52 $12.75M -$2.17M 2 2007-02-23

Recent Filings

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-05-11 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) — $0 EDGAR
2017-05-15 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) — $0 EDGAR
2016-05-06 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) — $0 EDGAR
2016-03-02 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +44,000 $26.4K EDGAR
2015-12-28 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +100 $79 EDGAR
2015-12-23 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +1,907 $1.5K EDGAR
2015-12-21 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +39,900 $31.1K EDGAR
2015-05-20 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +24,500 $30.6K EDGAR
2015-05-08 Oncternal Therapeutics, Inc. (GTXI) Delisted Grant (A) — $0 EDGAR
2015-04-23 Oncternal Therapeutics, Inc. (GTXI) Delisted Buy (P) +10,000 $7.2K EDGAR
Showing 1–10 of 35
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.